| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/15/2011 | CN101647956B Medicament for treating plague diseases and preparation method thereof |
| 06/15/2011 | CN101586120B Rabies virus Flury-LEP vaccine strain reverse genetic operating system and LEP green fluorescent protein recombination viral vector |
| 06/15/2011 | CN101585820B 1,2,3-selenadiazole thioacetanilides derivatives, preparation method thereof and application thereof |
| 06/15/2011 | CN101560216B Method for preparing cefditoren pivoxil |
| 06/15/2011 | CN101549152B Alliin/alliinase dualistic drug-releasing multilayer tablet |
| 06/15/2011 | CN101525336B Carbapenem compound containing substituted formohydrazide group |
| 06/15/2011 | CN101525323B Novel styryl chromone type compound and preparation method and use thereof |
| 06/15/2011 | CN101496898B Vaccine for preventing and/or treating Helicobacter pylori infection |
| 06/15/2011 | CN101455693B Centella total-glycoside diacolation-extracting method from centella |
| 06/15/2011 | CN101433619B Tinctura for eliminating tinea and relieving itching |
| 06/15/2011 | CN101428016B Uses of di-indole methyl hydride and its derivant in treating rheumatoid arthritis |
| 06/15/2011 | CN101411745B Antibiotic tanshinone extract, preparation method thereof, use and products produced thereby |
| 06/15/2011 | CN101401814B Clindamycin phosphate oral patches |
| 06/15/2011 | CN101400684B Thiazole compound |
| 06/15/2011 | CN101392020B Musca domestic pupae natural antimicrobial peptide products and preparation method and use thereof |
| 06/15/2011 | CN101357919B Penem derivative containing sulfhydryl formamide benzenesulfonyl pyrrolidine |
| 06/15/2011 | CN101357219B Medicine for treating chronic hepatitis B |
| 06/15/2011 | CN101322810B Chinese traditional medicine composition for treating diabetes respiratory tract infection |
| 06/15/2011 | CN101318006B Anti-bacterial, anti-itching externally used nursing formulation of traditional Chinese medicine |
| 06/15/2011 | CN101301451B Chinese medicine for treating liver disease |
| 06/15/2011 | CN101294188B Lactoferrin antimicrobial peptide, preparing method and uses thereof |
| 06/15/2011 | CN101284045B Highly effective skin lotion and preparation method thereof |
| 06/15/2011 | CN101274064B Chinese medicinal preparation for hydrophobic |
| 06/15/2011 | CN101235086B Recombination human rabies viruses resisting antibody |
| 06/15/2011 | CN101230067B Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 06/15/2011 | CN101219221B Adenovirus carrier vaccine carrying HIV gene |
| 06/15/2011 | CN101185679B Medicine for preventing and controlling pet damp-heat diarrhea |
| 06/15/2011 | CN101108835B Method of manufacturing high purity hydrochloric acid sarafloxacin |
| 06/15/2011 | CN101074252B 11,20-cyclic carbonate-azithromycin 4-phenproester derivative, its production and medicinal composition |
| 06/15/2011 | CN101074251B Azithromycin 4-phenproester derivative, its production and medicinal composition |
| 06/15/2011 | CN101065118B A composition comprising at least 3 different diols |
| 06/15/2011 | CN101056855B Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 06/15/2011 | CN101032489B Cefprozil dispersible table and the preparing method |
| 06/15/2011 | CA2725435A1 Vaccines for inclusion body hepatitis |
| 06/14/2011 | US7960535 Recombinant lipidated PsaA protein, methods of preparation and use |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960427 Antivirals against Hepatitis B, HIV, and influenza viruses; e.g. ethyl 2-[(benzo[d]imidazol-2-yl)thiomethyl]-6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-1H-indole-3-carboxylate |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960387 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses |
| 06/14/2011 | US7960366 Substituted tetracycline compounds as synergistic antifungal agents |
| 06/14/2011 | US7960351 Method for producing pectin hydrolysis products |
| 06/14/2011 | US7959927 Mycoplasma hyopneumoniae bacterin vaccine |
| 06/14/2011 | CA2527657C Modified fluorinated nucleoside analogues |
| 06/14/2011 | CA2517147C Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/14/2011 | CA2480987C Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 06/14/2011 | CA2468906C Use of selenite-containing compounds to be topically or buccally administered |
| 06/14/2011 | CA2456235C Heterocyclylarylsulphonamides |
| 06/14/2011 | CA2446260C Novel expression vectors and uses thereof |
| 06/14/2011 | CA2433667C Prodrugs of excitatory amino acids |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/14/2011 | CA2413546C Modification of hepatitis b core antigen |
| 06/14/2011 | CA2399846C Gm-negative ehv-mutants |
| 06/14/2011 | CA2382331C Vaccine against intra-cellular pathogens |
| 06/14/2011 | CA2365416C Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 06/14/2011 | CA2349490C Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
| 06/14/2011 | CA2328159C Use of aminoalkylphosphonic acid derivatives for the therapeutic and preventative treatment of infections |
| 06/14/2011 | CA2327389C Dna vaccine for horses containing as at least one adjuvant, polymers of acrylic or methacrylic acid, or copolymers of maleic anhydride and ethylene |
| 06/14/2011 | CA2297786C New immunoprotective influenza antigen and its use in vaccination |
| 06/09/2011 | WO2011068941A2 Proline derivatives |
| 06/09/2011 | WO2011068271A1 Method for manufacturing a silica powder coated with an antibacterial agent, and topical dermatological composition including same |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011068143A1 Antibody against influenza virus subtype h5 and use thereof |
| 06/09/2011 | WO2011068136A1 Pharmaceutical agent comprising antibody capable of binding specifically to ganglioside gd3 |
| 06/09/2011 | WO2011067607A1 Treatment of infectious diseases |
| 06/09/2011 | WO2011067501A1 Local topical application aminosteroid compounds for mucous/cutaneous decolonization of staphylococcus aureus |
| 06/09/2011 | WO2011067335A1 Use of defensins for treatment of infective endocarditis |
| 06/09/2011 | WO2011067302A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
| 06/09/2011 | WO2011067236A2 Raltegravir polymorphs |
| 06/09/2011 | WO2011066735A1 An Amorolfine HCl Crystal and the Preparation thereof |
| 06/09/2011 | WO2010149947A3 Antimicrobial agent |
| 06/09/2011 | WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 06/09/2011 | US20110136918 Methods of Treating Infectious Diseases |
| 06/09/2011 | US20110136912 Ophthalmic emulsion |
| 06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
| 06/09/2011 | US20110136895 Methods and compositions for modulating PD1 |
| 06/09/2011 | US20110136893 Oligonucleotide-, protein and/or peptide-polymer conjugates |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136840 Anti-infective agents |
| 06/09/2011 | US20110136837 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/09/2011 | US20110136834 Inhibitors of e1 activating enzymes |
| 06/09/2011 | US20110136829 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 06/09/2011 | US20110136823 Compounds having a potentiating effect on the activity of ethionamide and uses thereof |
| 06/09/2011 | US20110136822 Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof |
| 06/09/2011 | US20110136812 Solubilized topoisomerase poisons |
| 06/09/2011 | US20110136801 Novel Compounds |
| 06/09/2011 | US20110136799 Proline derivatives |
| 06/09/2011 | US20110136796 IDO Inhibitors |
| 06/09/2011 | US20110136795 Tricyclic alkylaminomethyloxazolidinone derivatives |
| 06/09/2011 | US20110136789 C-met protein kinase inhibitors |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136763 Trisubstituted boron-containing molecules |
| 06/09/2011 | US20110136759 Moenomycin analogs, methods of synthesis, and uses thereof |
| 06/09/2011 | US20110136758 Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens |
| 06/09/2011 | US20110136757 Hypersulfated disaccharide formulations |
| 06/09/2011 | US20110136752 Novel antibiotics |